\n 适用生物\xa0\xa0 \xa0Homo sapiens (Human,人)
肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒
检测范围\xa0\xa0 \xa00.156-10ng/mL\xa0\xa0 \xa0灵敏度\xa0\xa0 \xa00.063ng/mL
样本类型\xa0\xa0 \xa0Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
实验时长\xa0\xa0 \xa04.5h\xa0\xa0 \xa0实验方法\xa0\xa0 \xa0双抗夹心法 \xa0\xa0
规格\xa0\xa0 \xa096T
肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒
ELISA Kit for Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
ELISA Kit for Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
\t\t\t\t\t\t| Organism species | \t\t\tHomo sapiens (Human) | \t\t
\t\t\t\t\t| Product No. | \t\t\tSEA139Hu | \t\t
\t\t\t\t\t| Sample type | \t\t\tSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. | \t\t
\t\t\t\t\t| Format | \t\t\t96T | \t\t
\t\t\t\t\t| Assay length | \t\t\t4.5 hours | \t\t
\t\t\t\t\t| Detection range | \t\t\t0.156-10ng/mL The standard curve concentrations used for the ELISA’s were 10ng/mL, 5ng/mL, 2.5ng/mL, 1.25ng/mL, 0.625ng/mL, 0.313ng/mL, 0.156ng/mL | \t\t
\t\t\t\t\t| Sensitivity | \t\t\tThe minimum detectable dose of this kit is typically less than 0.063ng/mL. | \t\t
\t
\t\t\t\t\t\t| Organism species | \t\t\tHomo sapiens (Human) | \t\t
\t\t\t\t\t| Product No. | \t\t\tSEA139Hu | \t\t
\t\t\t\t\t| Sample type | \t\t\tSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. | \t\t
\t\t\t\t\t| Format | \t\t\t96T | \t\t
\t\t\t\t\t| Assay length | \t\t\t4.5 hours | \t\t
\t\t\t\t\t| Detection range | \t\t\t0.156-10ng/mL The standard curve concentrations used for the ELISA’s were 10ng/mL, 5ng/mL, 2.5ng/mL, 1.25ng/mL, 0.625ng/mL, 0.313ng/mL, 0.156ng/mL | \t\t
\t\t\t\t\t| Sensitivity | \t\t\tThe minimum detectable dose of this kit is typically less than 0.063ng/mL. | \t\t
\t
\t
\t\t\t\t\t| Organism species | \t\t\tHomo sapiens (Human) | \t\t
\t\t\t\t\t| Product No. | \t\t\tSEA139Hu | \t\t
\t\t\t\t\t| Sample type | \t\t\tSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. | \t\t
\t\t\t\t\t| Format | \t\t\t96T | \t\t
\t\t\t\t\t| Assay length | \t\t\t4.5 hours | \t\t
\t\t\t\t\t| Detection range | \t\t\t0.156-10ng/mL The standard curve concentrations used for the ELISA’s were 10ng/mL, 5ng/mL, 2.5ng/mL, 1.25ng/mL, 0.625ng/mL, 0.313ng/mL, 0.156ng/mL | \t\t
\t\t\t\t\t| Sensitivity | \t\t\tThe minimum detectable dose of this kit is typically less than 0.063ng/mL. | \t\t
\t\t\t
\t\t\t| Organism species | \t\t\tHomo sapiens (Human) | \t\t
\t\t\t
Organism species | Organism speciesOrganism species\t\t\t
Homo sapiens (Human) | Homo sapiens (Human)\t\t\t\t
\t\t\t| Product No. | \t\t\tSEA139Hu | \t\t
\t\t\t
Product No. | Product No.Product No.\t\t\t
SEA139Hu | SEA139Hu\t\t\t\t
\t\t\t| Sample type | \t\t\tSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. | \t\t
\t\t\t
Sample type | Sample typeSample type\t\t\t
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. | Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.\t\t\t\t
\t\t\t| Format | \t\t\t96T | \t\t
\t\t\t
Format | FormatFormat\t\t\t
96T | 96T\t\t\t\t
\t\t\t| Assay length | \t\t\t4.5 hours | \t\t
\t\t\t
Assay length | Assay lengthAssay length\t\t\t
4.5 hours | 4.5 hours\t\t\t\t
\t\t\t| Detection range | \t\t\t0.156-10ng/mL The standard curve concentrations used for the ELISA’s were 10ng/mL, 5ng/mL, 2.5ng/mL, 1.25ng/mL, 0.625ng/mL, 0.313ng/mL, 0.156ng/mL | \t\t
\t\t\t
Detection range | Detection rangeDetection range\t\t\t
0.156-10ng/mL The standard curve concentrations used for the ELISA’s were 10ng/mL, 5ng/mL, 2.5ng/mL, 1.25ng/mL, 0.625ng/mL, 0.313ng/mL, 0.156ng/mL | 0.156-10ng/mL The standard curve concentrations used for the ELISA’s were 10ng/mL, 5ng/mL, 2.5ng/mL, 1.25ng/mL, 0.625ng/mL, 0.313ng/mL, 0.156ng/mL\t\t\t\t
\t\t\t| Sensitivity | \t\t\tThe minimum detectable dose of this kit is typically less than 0.063ng/mL. | \t\t
\t\t\t
Sensitivity | SensitivitySensitivity\t\t\t
The minimum detectable dose of this kit is typically less than 0.063ng/mL. | The minimum detectable dose of this kit is typically less than 0.063ng/mL.\t\t\t
Specificity
Specificity
This assay has high sensitivity and excellent specificity for detection of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL).\xa0
No significant cross-reactivity or interference between Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) and analogues was observed.
This assay has high sensitivity and excellent specificity for detection of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL).\xa0
No significant cross-reactivity or interference between Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) and analogues was observed.
Recovery
Recovery
肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒Matrices listed below were spiked with certain level of recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) and the recovery rates were calculated by comparing the measured value to the expected amount of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in samples.\xa0
\t\t\t\t\t\t| Matrix | \t\t\tRecovery range (%) | \t\t\tAverage(%) | \t\t
\t\t\t\t\t| serum(n=5) | \t\t\t79-89 | \t\t\t83 | \t\t
\t\t\t\t\t| EDTA plasma(n=5) | \t\t\t89-103 | \t\t\t97 | \t\t
\t\t\t\t\t| heparin plasma(n=5) | \t\t\t88-96 | \t\t\t92 | \t\t
\t
肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒Matrices listed below were spiked with certain level of recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) and the recovery rates were calculated by comparing the measured value to the expected amount of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in samples.\xa0
\t\t\t\t\t\t| Matrix | \t\t\tRecovery range (%) | \t\t\tAverage(%) | \t\t
\t\t\t\t\t| serum(n=5) | \t\t\t79-89 | \t\t\t83 | \t\t
\t\t\t\t\t| EDTA plasma(n=5) | \t\t\t89-103 | \t\t\t97 | \t\t
\t\t\t\t\t| heparin plasma(n=5) | \t\t\t88-96 | \t\t\t92 | \t\t
\t
\t
\t\t\t\t\t| Matrix | \t\t\tRecovery range (%) | \t\t\tAverage(%) | \t\t
\t\t\t\t\t| serum(n=5) | \t\t\t79-89 | \t\t\t83 | \t\t
\t\t\t\t\t| EDTA plasma(n=5) | \t\t\t89-103 | \t\t\t97 | \t\t
\t\t\t\t\t| heparin plasma(n=5) | \t\t\t88-96 | \t\t\t92 | \t\t
\t\t\t
\t\t\t| Matrix | \t\t\tRecovery range (%) | \t\t\tAverage(%) | \t\t
\t\t\t
Matrix | Matrix\t\t\t
Recovery range (%) | Recovery range (%)\t\t\t
Average(%) | Average(%)\t\t\t\t
\t\t\t| serum(n=5) | \t\t\t79-89 | \t\t\t83 | \t\t
\t\t\t
serum(n=5) | serum(n=5)\t\t\t
79-89 | 79-89\t\t\t
83 | 83\t\t\t\t
\t\t\t| EDTA plasma(n=5) | \t\t\t89-103 | \t\t\t97 | \t\t
\t\t\t
EDTA plasma(n=5) | EDTA plasma(n=5)\t\t\t
89-103 | 89-103\t\t\t
97 | 97\t\t\t\t
\t\t\t| heparin plasma(n=5) | \t\t\t88-96 | \t\t\t92 | \t\t
\t\t\t
heparin plasma(n=5) | heparin plasma(n=5)\t\t\t
88-96 | 88-96\t\t\t
92 | 92\t\t\t
Precision
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) were tested 20 times on one plate, respectively.\xa0
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) were tested on 3 different plates, 8 replicates in each plate.\xa0
CV(%) = SD/meanX100\xa0
Intra-Assay: CV<10%\xa0
Inter-Assay: CV<12%\xa0
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) were tested 20 times on one plate, respectively.\xa0
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) were tested on 3 different plates, 8 replicates in each plate.\xa0
CV(%) = SD/meanX100\xa0
Intra-Assay: CV<10%\xa0
Inter-Assay: CV<12%\xa0
Linearity
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.\xa0
\t\t\t\t\t\t| Sample | \t\t\t1:2 | \t\t\t1:4 | \t\t\t1:8 | \t\t\t1:16 | \t\t
\t\t\t\t\t| serum(n=5) | \t\t\t81-91% | \t\t\t79-98% | \t\t\t96-104% | \t\t\t82-91% | \t\t
\t\t\t\t\t| EDTA plasma(n=5) | \t\t\t95-103% | \t\t\t93-105% | \t\t\t88-101% | \t\t\t95-105% | \t\t
\t\t\t\t\t| heparin plasma(n=5) | \t\t\t81-104% | \t\t\t98-105% | \t\t\t85-99% | \t\t\t93-102% | \t\t
\t
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.\xa0
\t\t\t\t\t\t| Sample | \t\t\t1:2 | \t\t\t1:4 | \t\t\t1:8 | \t\t\t1:16 | \t\t
\t\t\t\t\t| serum(n=5) | \t\t\t81-91% | \t\t\t79-98% | \t\t\t96-104% | \t\t\t82-91% | \t\t
\t\t\t\t\t| EDTA plasma(n=5) | \t\t\t95-103% | \t\t\t93-105% | \t\t\t88-101% | \t\t\t95-105% | \t\t
\t\t\t\t\t| heparin plasma(n=5) | \t\t\t81-104% | \t\t\t98-105% | \t\t\t85-99% | \t\t\t93-102% | \t\t
\t
\t
\t\t\t\t\t| Sample | \t\t\t1:2 | \t\t\t1:4 | \t\t\t1:8 | \t\t\t1:16 | \t\t
\t\t\t\t\t| serum(n=5) | \t\t\t81-91% | \t\t\t79-98% | \t\t\t96-104% | \t\t\t82-91% | \t\t
\t\t\t\t\t| EDTA plasma(n=5) | \t\t\t95-103% | \t\t\t93-105% | \t\t\t88-101% | \t\t\t95-105% | \t\t
\t\t\t\t\t| heparin plasma(n=5) | \t\t\t81-104% | \t\t\t98-105% | \t\t\t85-99% | \t\t\t93-102% | \t\t
\t\t\t
\t\t\t| Sample | \t\t\t1:2 | \t\t\t1:4 | \t\t\t1:8 | \t\t\t1:16 | \t\t
\t\t\t
Sample | Sample\t\t\t
1:2 | 1:2\t\t\t
1:4 | 1:4\t\t\t
1:8 | 1:8\t\t\t
1:16 | 1:16\t\t\t\t
\t\t\t| serum(n=5) | \t\t\t81-91% | \t\t\t79-98% | \t\t\t96-104% | \t\t\t82-91% | \t\t
\t\t\t
serum(n=5) | serum(n=5)\t\t\t
81-91% | 81-91%\t\t\t
79-98% | 79-98%\t\t\t
96-104% | 96-104%\t\t\t
82-91% | 82-91%\t\t\t\t
\t\t\t| EDTA plasma(n=5) | \t\t\t95-103% | \t\t\t93-105% | \t\t\t88-101% | \t\t\t95-105% | \t\t
\t\t\t
EDTA plasma(n=5) | EDTA plasma(n=5)\t\t\t
95-103% | 95-103%\t\t\t
93-105% | 93-105%\t\t\t
88-101% | 88-101%\t\t\t
95-105% | 95-105%\t\t\t\t
\t\t\t| heparin plasma(n=5) | \t\t\t81-104% | \t\t\t98-105% | \t\t\t85-99% | \t\t\t93-102% | \t\t
\t\t\t
heparin plasma(n=5) | heparin plasma(n=5)\t\t\t
81-104% | 81-104%\t\t\t
98-105% | 98-105%\t\t\t
85-99% | 85-99%\t\t\t
93-102% | 93-102%\t\t\t
Stability
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.\xa0
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.\xa0
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents and materials provided
\t\t\t\t\t\t| Reagents | \t\t\tQuantity | \t\t\tReagents | \t\t\tQuantity | \t\t
\t\t\t\t\t| Pre-coated, ready to use 96-well strip plate | \t\t\t1 | \t\t\tPlate sealer for 96 wells | \t\t\t4 | \t\t
\t\t\t\t\t| Standard | \t\t\t2 | \t\t\tStandard Diluent | \t\t\t1×20mL | \t\t
\t\t\t\t\t| Detection Reagent A | \t\t\t1×120μL | \t\t\tAssay Diluent A | \t\t\t1×12mL | \t\t
\t\t\t\t\t| Detection Reagent B | \t\t\t1×120μL | \t\t\tAssay Diluent B | \t\t\t1×12mL | \t\t
\t\t\t\t\t| TMB Substrate | \t\t\t1×9mL | \t\t\tStop Solution | \t\t\t1×6mL | \t\t
\t\t\t\t\t| Wash Buffer (30 × concentrate) | \t\t\t1×20mL | \t\t\tInstruction manual | \t\t\t1 | \t\t
\t
\t\t\t\t\t\t| Reagents | \t\t\tQuantity | \t\t\tReagents | \t\t\tQuantity | \t\t
\t\t\t\t\t| Pre-coated, ready to use 96-well strip plate | \t\t\t1 | \t\t\tPlate sealer for 96 wells | \t\t\t4 | \t\t
\t\t\t\t\t| Standard | \t\t\t2 | \t\t\tStandard Diluent | \t\t\t1×20mL | \t\t
\t\t\t\t\t| Detection Reagent A | \t\t\t1×120μL | \t\t\tAssay Diluent A | \t\t\t1×12mL | \t\t
\t\t\t\t\t| Detection Reagent B | \t\t\t1×120μL | \t\t\tAssay Diluent B | \t\t\t1×12mL | \t\t
\t\t\t\t\t| TMB Substrate | \t\t\t1×9mL | \t\t\tStop Solution | \t\t\t1×6mL | \t\t
\t\t\t\t\t| Wash Buffer (30 × concentrate) | \t\t\t1×20mL | \t\t\tInstruction manual | \t\t\t1 | \t\t
\t
\t
\t\t\t\t\t| Reagents | \t\t\tQuantity | \t\t\tReagents | \t\t\tQuantity | \t\t
\t\t\t\t\t| Pre-coated, ready to use 96-well strip plate | \t\t\t1 | \t\t\tPlate sealer for 96 wells | \t\t\t4 | \t\t
\t\t\t\t\t| Standard | \t\t\t2 | \t\t\tStandard Diluent | \t\t\t1×20mL | \t\t
\t\t\t\t\t| Detection Reagent A | \t\t\t1×120μL | \t\t\tAssay Diluent A | \t\t\t1×12mL | \t\t
\t\t\t\t\t| Detection Reagent B | \t\t\t1×120μL | \t\t\tAssay Diluent B | \t\t\t1×12mL | \t\t
\t\t\t\t\t| TMB Substrate | \t\t\t1×9mL | \t\t\tStop Solution | \t\t\t1×6mL | \t\t
\t\t\t\t\t| Wash Buffer (30 × concentrate) | \t\t\t1×20mL | \t\t\tInstruction manual | \t\t\t1 | \t\t
\t\t\t
\t\t\t| Reagents | \t\t\tQuantity | \t\t\tReagents | \t\t\tQuantity | \t\t
\t\t\t
Reagents | Reagents\t\t\t
Quantity | Quantity\t\t\t
Reagents | Reagents\t\t\t
Quantity | Quantity\t\t\t\t
\t\t\t| Pre-coated, ready to use 96-well strip plate | \t\t\t1 | \t\t\tPlate sealer for 96 wells | \t\t\t4 | \t\t
\t\t\t
Pre-coated, ready to use 96-well strip plate | Pre-coated, ready to use 96-well strip plate\t\t\t
1 | 1\t\t\t
Plate sealer for 96 wells | Plate sealer for 96 wells\t\t\t
4 | 4\t\t\t\t
\t\t\t| Standard | \t\t\t2 | \t\t\tStandard Diluent | \t\t\t1×20mL | \t\t
\t\t\t
Standard | Standard\t\t\t
2 | 2\t\t\t
Standard Diluent | Standard Diluent\t\t\t
1×20mL | 1×20mL\t\t\t\t
\t\t\t| Detection Reagent A | \t\t\t1×120μL | \t\t\tAssay Diluent A | \t\t\t1×12mL | \t\t
\t\t\t
Detection Reagent A | Detection Reagent A\t\t\t
1×120μL | 1×120μL\t\t\t
Assay Diluent A | Assay Diluent A\t\t\t
1×12mL | 1×12mL\t\t\t\t
\t\t\t| Detection Reagent B | \t\t\t1×120μL | \t\t\tAssay Diluent B | \t\t\t1×12mL | \t\t
\t\t\t
Detection Reagent B | Detection Reagent B\t\t\t
1×120μL | 1×120μL\t\t\t
Assay Diluent B | Assay Diluent B\t\t\t
1×12mL | 1×12mL\t\t\t\t
\t\t\t| TMB Substrate | \t\t\t1×9mL | \t\t\tStop Solution | \t\t\t1×6mL | \t\t
\t\t\t
TMB Substrate | TMB Substrate\t\t\t
1×9mL | 1×9mL\t\t\t
Stop Solution | Stop Solution\t\t\t
1×6mL | 1×6mL\t\t\t\t
\t\t\t| Wash Buffer (30 × concentrate) | \t\t\t1×20mL | \t\t\tInstruction manual | \t\t\t1 | \t\t
\t\t\t
Wash Buffer (30 × concentrate) | Wash Buffer (30 × concentrate)\t\t\t
1×20mL | 1×20mL\t\t\t
Instruction manual | Instruction manual\t\t\t
1 | 1\t\t\t
Assay procedure summary
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100μL standard or sample to each well. Incubate 2 hours at 37oC;
3. Aspirate and add 100μL prepared Detection Reagent A. Incubate 1 hour at 37oC;
4. Aspirate and wash 3 times;
5. Add 100μL prepared Detection Reagent B. Incubate 30 minutes at 37oC;
6. Aspirate and wash 5 times;
7. Add 90μL Substrate Solution. Incubate 15-25 minutes at 37oC;
8. Add 50μL Stop Solution. Read at 450nm immediately.\xa0
1. Prepare all reagents, samples and standards;
2. Add 100μL standard or sample to each well. Incubate 2 hours at 37
ooC;
3. Aspirate and add 100μL prepared Detection Reagent A. Incubate 1 hour at 37
ooC;
4. Aspirate and wash 3 times;
5. Add 100μL prepared Detection Reagent B. Incubate 30 minutes at 37
ooC;
6. Aspirate and wash 5 times;
7. Add 90μL Substrate Solution. Incubate 15-25 minutes at 37
ooC;
8. Add 50μL Stop Solution. Read at 450nm immediately.\xa0
Test principle
Test principle
肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒肿瘤坏死因子相关凋亡诱导配体(TRAIL)检测试剂盒The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
yb-E10607\xa0\xa0 \xa0人阿米巴(Amebiasis)ELISA试剂盒\xa0\xa0 \xa0People amoeba (Amebiasis) ELISA kit
yb-E10608\xa0\xa0 \xa0人白喉抗体(Diphtheria Ab)ELISA试剂盒\xa0\xa0 \xa0Human diphtheria antibody (Diphtheria Ab) ELISA kit
yb-E10609\xa0\xa0 \xa0人囊虫病抗体(CYT Ab)ELISA试剂盒\xa0\xa0 \xa0Human cysticercosis antibody (CYT Ab) ELISA kit
yb-E10610\xa0\xa0 \xa0人布鲁氏菌抗体IgG(Brucella Ab IgG)ELISA试剂盒\xa0\xa0 \xa0People Brucella antibody IgG (Brucella Ab IgG) ELISA Kit
yb-E10611\xa0\xa0 \xa0人水痘带状疱疹病毒IgM(VZV-IgM)ELISA试剂盒\xa0\xa0 \xa0People varicella zoster virus IgM (VZV-IgM) ELISA kit
yb-E10612\xa0\xa0 \xa0人水痘带状疱疹病毒IgG(VZV-IgG)ELISA试剂盒\xa0\xa0 \xa0Varicella -zoster virus human IgG (VZV-IgG) ELISA Kit
yb-E10613\xa0\xa0 \xa0人军团菌抗体IgA(LP Ab-IgA)ELISA试剂盒\xa0\xa0 \xa0Legionella human antibody IgA (LP Ab-IgA) ELISA kit
yb-E10614\xa0\xa0 \xa0人军团菌抗体IgM(LP Ab-IgM )ELISA试剂盒\xa0\xa0 \xa0Legionella human antibody IgM (LP Ab-IgM) ELISA kit
yb-E10615\xa0\xa0 \xa0人军团菌抗体IgG(LP Ab-IgG)ELISA试剂盒\xa0\xa0 \xa0Legionella human antibody IgG (LP Ab-IgG) ELISA Kit
yb-E10616\xa0\xa0 \xa0人腮腺炎病毒IgM ELISA试剂盒\xa0\xa0 \xa0Human mumps virus IgM ELISA kit
yb-E10617\xa0\xa0 \xa0人腮腺炎病毒IgG ELISA试剂盒\xa0\xa0 \xa0Mumps virus, human IgG ELISA kit
yb-E10618\xa0\xa0 \xa0人EB病毒IgM(EBv IgM)ELISA试剂盒\xa0\xa0 \xa0People EB virus IgM (EBv IgM) ELISA kit
yb-E10619\xa0\xa0 \xa0人EB病毒IgA(EBv IgA)ELISA试剂盒\xa0\xa0 \xa0EB virus human IgA (EBv IgA) ELISA Kit
yb-E10620\xa0\xa0 \xa0人EB病毒IgG(EBv IgG)ELISA试剂盒\xa0\xa0 \xa0EB virus human IgG (EBv IgG) ELISA Kit
yb-E10621\xa0\xa0 \xa0人利什曼原虫抗体(Leishimaria Ab)ELISA试剂盒\xa0\xa0 \xa0Leishmania human antibody (Leishimaria Ab) ELISA Kit
yb-E10622\xa0\xa0 \xa0人登革热抗体(DF-Ab)ELISA试剂盒\xa0\xa0 \xa0Dengue human antibody (DF-Ab) ELISA Kit
yb-E10623\xa0\xa0 \xa0人流感病毒抗体IgG(FLU)ELISA试剂盒\xa0\xa0 \xa0Human influenza virus antibody IgG (FLU) ELISA Kit
yb-E10624\xa0\xa0 \xa0人腺病毒IgM(ADV-IgM)ELISA试剂盒\xa0\xa0 \xa0Human adenovirus IgM (ADV-IgM) ELISA Kit
yb-E10625\xa0\xa0 \xa0人腺病毒IgG(ADV-IgG)ELISA试剂盒\xa0\xa0 \xa0Human adenovirus IgG (ADV-IgG) ELISA Kit
yb-E10626\xa0\xa0 \xa0人轮状病毒(RV)IgM ELISA试剂盒\xa0\xa0 \xa0Human rotavirus (RV) IgM ELISA kit
yb-E10627\xa0\xa0 \xa0人艾柯病毒IgM(ECHO IgM)ELISA试剂盒\xa0\xa0 \xa0People echovirus IgM (ECHO IgM) ELISA kit
yb-E10628\xa0\xa0 \xa0人抗呼吸道合胞病毒抗体(RSV)ELISA试剂盒\xa0\xa0 \xa0Human antibodies against respiratory syncytial virus (RSV) ELISA kit
yb-E10629\xa0\xa0 \xa0人麻疹病毒IgM(MV IgM)ELISA试剂盒\xa0\xa0 \xa0Human measles virus IgM (MV IgM) ELISA kit
yb-E10630\xa0\xa0 \xa0人柯萨奇病毒IgM(Cox V-IgM)ELISA试剂盒\xa0\xa0 \xa0People Coxsackie virus IgM (Cox V-IgM) ELISA kit
yb-E10631\xa0\xa0 \xa0人柯萨奇病毒IgG(Cox V-IgG)ELISA试剂盒\xa0\xa0 \xa0Human coxsackie virus IgG (Cox V-IgG) ELISA Kit
yb-E10632\xa0\xa0 \xa0人结核菌杆抗体IgG(TB-Ab IgG)ELISA试剂盒\xa0\xa0 \xa0TB rod human antibody IgG (TB-Ab IgG) ELISA Kit